223 related articles for article (PubMed ID: 3916488)
21. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
22. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages.
Azzawi M; Hasleton PS; Geraghty PJ; Yonan N; Krysiak P; El-Gammal A; Deiraniya AK; Hutchinson IV
J Heart Lung Transplant; 1998 Sep; 17(9):881-7. PubMed ID: 9773860
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of action of cyclosporine in preventing cardiac allograft rejection. I. Rate of entry of lymphocytes from the blood, fibrin deposition, and expression of Ia antigens on infiltrating cells.
Cox JH; Chisholm PM
Transplantation; 1987 Mar; 43(3):338-42. PubMed ID: 3547786
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine induced myocardial fibrosis: a unique controlled case report.
Karch SB; Billingham ME
J Heart Transplant; 1985 Feb; 4(2):210-2. PubMed ID: 3916487
[TBL] [Abstract][Full Text] [Related]
25. Xenogeneic and allogeneic canine heart transplantation: a model for cytologic and immunologic monitoring of rejection mechanisms.
Reichenspurner H; Ertel W; Reichart B; Peters D; Welz A; Uberfuhr P; Kemkes BM; Gokel JM; Hammer C
J Heart Transplant; 1986; 5(6):471-6. PubMed ID: 3302180
[TBL] [Abstract][Full Text] [Related]
26. Predictive implications of bioptic diagnosis in cardiac allografts.
Kemnitz J; Choritz H; Cohnert TR; Haverich A; Borst HG; Georgii A
J Heart Transplant; 1989; 8(4):315-29. PubMed ID: 2671317
[TBL] [Abstract][Full Text] [Related]
27. Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection.
Sorrentino C; Scarinci A; D'Antuono T; Piccirilli M; Di Nicola M; Pasquale M; Di Iorio C; Di Carlo E
J Pathol; 2006 Jul; 209(3):400-10. PubMed ID: 16583358
[TBL] [Abstract][Full Text] [Related]
28. Randomized study of high dose oral cyclosporine therapy for mild acute cardiac rejection.
Kobashigawa J; Stevenson LW; Moriguchi J; Westlake C; Wilmarth J; Kawata N; Chuck C; Lewis W; Drinkwater D; Laks H
J Heart Transplant; 1989; 8(1):53-8. PubMed ID: 2647933
[TBL] [Abstract][Full Text] [Related]
29. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
30. The cellular target of cyclosporin A action in humans.
Van Buren CT; Kerman R; Agostino G; Payne W; Flechner S; Kahan BD
Surgery; 1982 Aug; 92(2):167-74. PubMed ID: 6213052
[TBL] [Abstract][Full Text] [Related]
31. Comparison of myocardial cell injury in acute cellular rejection versus acute vascular rejection in cyclosporine-treated heart transplants.
Hook S; Caple JF; McMahon JT; Myles JL; Ratliff NB
J Heart Lung Transplant; 1995; 14(2):351-8. PubMed ID: 7779856
[TBL] [Abstract][Full Text] [Related]
32. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
[TBL] [Abstract][Full Text] [Related]
33. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
34. Long-term management and results in heart transplant recipients.
Valantine HA
Cardiol Clin; 1990 Feb; 8(1):141-8. PubMed ID: 2407355
[TBL] [Abstract][Full Text] [Related]
35. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
[No Abstract] [Full Text] [Related]
36. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
Nohria A; Ehtisham J; Ramahi TM
J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.
Si L; Whiteside TL; Van Thiel DH; Rabin BS
Lab Invest; 1984 Mar; 50(3):341-7. PubMed ID: 6366363
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
[No Abstract] [Full Text] [Related]
39. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes.
Hruban RH; Beschorner WE; Baumgartner WA; Achuff SC; Traill TA; Marsh BR; Gupta PK; Hutchins GM; Reitz BA
J Thorac Cardiovasc Surg; 1988 Dec; 96(6):939-46. PubMed ID: 3057293
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts.
Briscoe DM; Yeung AC; Schoen FJ; Allred EN; Stavrakis G; Ganz P; Cotran RS; Pober JS; Schoen EL
Transplantation; 1995 Jan; 59(2):204-11. PubMed ID: 7530872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
